Full text is available at the source.
Evaluating the breadth of nucleic acid-based payloads delivered in lipid nanoparticles to establish fundamental differences in development
Comparing different genetic materials delivered by lipid nanoparticles to understand key development differences
AI simplified
Abstract
Nucleic acid-based therapeutics may require optimized delivery systems to target specific tissues effectively.
- Clinical applications of nucleic acid-based therapeutics include antisense oligonucleotides, small interfering RNA, messenger RNA, and circular RNA.
- Lipid nanoparticle technology is highlighted for its role in delivering these therapeutics into cells.
- Understanding the trafficking of lipid nanoparticles at systemic and cellular levels is essential for improving targeted delivery.
- NA-based vaccines focus on targeting antigen-presenting cells to activate the immune system.
- Prolonged systemic circulation and enhanced endosomal escape are crucial for effective delivery of nucleic acid payloads.
- Further studies on the pharmacokinetics of both the therapeutic cargo and its delivery carrier are needed, as their behaviors may differ.
AI simplified